Breaking News

Monday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
CareRx price target lowered to C$8.50 from C$10 at Desjardins » 11:51
05/16/22
05/16
11:51
05/16/22
11:51
CHHHF

CareRx

$3.51 /

-0.22 (-5.90%)

Desjardins analyst David…

Desjardins analyst David Newman lowered the firm's price target on CareRx to C$8.50 from C$10 and keeps a Buy rating on the shares.

ShowHide Related Items >><<
CHHHF CareRx
$3.51 /

-0.22 (-5.90%)

05/13/22 Canaccord
CareRx price target lowered to C$8 from C$8.50 at Canaccord
03/22/22 Desjardins
CareRx price target raised to C$10 from C$9.50 at Desjardins
11/10/21 Canaccord
CareRx price target raised to C$8.50 from C$8.25 at Canaccord
05/21/21 Desjardins
CareRx price target raised to C$10 from C$7.50 at Desjardins
Over a week ago
Recommendations
CareRx price target lowered to C$8 from C$8.50 at Canaccord » 14:31
05/13/22
05/13
14:31
05/13/22
14:31
CHHHF

CareRx

$3.73 /

-0.192 (-4.90%)

Canaccord analyst Tania…

Canaccord analyst Tania Gonsalves lowered the firm's price target on CareRx to C$8 from C$8.50 and keeps a Buy rating on the shares.

ShowHide Related Items >><<
CHHHF CareRx
$3.73 /

-0.192 (-4.90%)

03/22/22 Desjardins
CareRx price target raised to C$10 from C$9.50 at Desjardins
11/10/21 Canaccord
CareRx price target raised to C$8.50 from C$8.25 at Canaccord
05/21/21 Desjardins
CareRx price target raised to C$10 from C$7.50 at Desjardins
05/20/21 Canaccord
CareRx price target raised to C$9 from C$7 at Canaccord
Conference/Events
Bloom Burton Securities to hold conference » 04:55
05/03/22
05/03
04:55
05/03/22
04:55
ABCL

AbCellera

$8.08 /

+0.395 (+5.14%)

, BLU

Bellus Health

$8.97 /

+0.915 (+11.37%)

, CHHHF

CareRx

$4.05 /

+ (+0.00%)

, EPIX

Essa Pharma

$5.80 /

+0.155 (+2.75%)

, ESSA

ESSA Bancorp

$17.25 /

-0.2 (-1.15%)

, FTRP

Field Trip Health

$1.05 /

+ (+0.00%)

, FUSN

Fusion Pharmaceuticals

$5.17 /

+ (+0.00%)

, HLTRF

HLS Therapeutics

$10.92 /

-0.0397 (-0.36%)

, IGXT

IntelGenx

/

+

, KDNY

Chinook Therapeutics

$16.00 /

+0.865 (+5.72%)

, MDNA

Medicenna Therapeutics

$1.16 /

+0.06 (+5.45%)

, NVCN

Neovasc

$6.15 /

-0.23 (-3.61%)

, ONCY

Oncolytics

$1.38 /

+0.06 (+4.55%)

, PNT

Point Biopharma

$8.88 /

+0.34 (+3.98%)

, PROF

Profound Medical

$7.62 /

+0.17 (+2.28%)

, THER

Theratechnologies

/

+

, RPTX

Repare Therapeutics

$11.52 /

+0.495 (+4.49%)

, XENE

Xenon Pharmaceuticals

$29.08 /

+0.82 (+2.90%)

, ZYME

Zymeworks

$6.88 /

+0.76 (+12.42%)

Healthcare Investor…

Healthcare Investor Conference to be held in Toronto, Canada on May 2-3.

ShowHide Related Items >><<
ZYME Zymeworks
$6.88 /

+0.76 (+12.42%)

XENE Xenon Pharmaceuticals
$29.08 /

+0.82 (+2.90%)

RPTX Repare Therapeutics
$11.52 /

+0.495 (+4.49%)

PROF Profound Medical
$7.62 /

+0.17 (+2.28%)

PNT Point Biopharma
$8.88 /

+0.34 (+3.98%)

ONCY Oncolytics
$1.38 /

+0.06 (+4.55%)

NVCN Neovasc
$6.15 /

-0.23 (-3.61%)

MDNA Medicenna Therapeutics
$1.16 /

+0.06 (+5.45%)

KDNY Chinook Therapeutics
$16.00 /

+0.865 (+5.72%)

IGXT IntelGenx
/

+

HLTRF HLS Therapeutics
$10.92 /

-0.0397 (-0.36%)

FUSN Fusion Pharmaceuticals
$5.17 /

+ (+0.00%)

FTRP Field Trip Health
$1.05 /

+ (+0.00%)

EPIX Essa Pharma
$5.80 /

+0.155 (+2.75%)

BLU Bellus Health
$8.97 /

+0.915 (+11.37%)

ABCL AbCellera
$8.08 /

+0.395 (+5.14%)

ABCL AbCellera
$8.08 /

+0.395 (+5.14%)

04/28/22 Piper Sandler
AbCellera Q1 royalty estimate raised at Piper after Eli Lilly report
02/25/22 Piper Sandler
AbCellera price target lowered to $28 from $33 at Piper Sandler
02/11/22 Benchmark
AbCellera royalties could be 'substantial' from Lilly antibody, says Benchmark
12/21/21 Benchmark
AbCellera initiated with a Buy at Benchmark
BLU Bellus Health
$8.97 /

+0.915 (+11.37%)

02/24/22 H.C. Wainwright
Bellus Health price target raised to $16 from $14 at H.C. Wainwright
12/14/21 BTIG
Bellus Health price target raised to $18 from $13 at BTIG
12/13/21 BTIG
Bellus Health price target raised to $18 from $13 at BTIG
12/13/21 Evercore ISI
Bellus Health price target raised to $20 from $12 at Evercore ISI
CHHHF CareRx
$4.05 /

+ (+0.00%)

03/22/22 Desjardins
CareRx price target raised to C$10 from C$9.50 at Desjardins
11/10/21 Canaccord
CareRx price target raised to C$8.50 from C$8.25 at Canaccord
05/21/21 Desjardins
CareRx price target raised to C$10 from C$7.50 at Desjardins
05/20/21 Canaccord
CareRx price target raised to C$9 from C$7 at Canaccord
EPIX Essa Pharma
$5.80 /

+0.155 (+2.75%)

08/16/21 Oppenheimer
Essa Pharma price target lowered to $22 from $36 at Oppenheimer
08/16/21 Piper Sandler
Essa Pharma readout delay raises some concerns, says Pper Sandler
ESSA ESSA Bancorp
$17.25 /

-0.2 (-1.15%)

FTRP Field Trip Health
$1.05 /

+ (+0.00%)

02/17/22 Stifel
Field Trip Health price target lowered to C$10.50 from C$11.50 at Stifel
11/22/21 H.C. Wainwright
Field Trip Health price target raised to $25 from $20 at H.C. Wainwright
11/18/21 Stifel
Field Trip Health price target raised to C$11.50 from C$10 at Stifel
09/01/21 H.C. Wainwright
Field Trip Health initiated with a Buy at H.C. Wainwright
FUSN Fusion Pharmaceuticals
$5.17 /

+ (+0.00%)

10/19/21 Morgan Stanley
Fusion Pharmaceuticals assumed with an Overweight at Morgan Stanley
08/26/21 B. Riley
B. Riley starts Fusion Pharmaceuticals with Buy, sees over 100% upside
08/26/21 B. Riley
Fusion Pharmaceuticals initiated with a Buy at B. Riley
HLTRF HLS Therapeutics
$10.92 /

-0.0397 (-0.36%)

04/27/22 Canaccord
HLS Therapeutics price target lowered to C$27 from C$30.50 at Canaccord
04/27/22 Clarus
HLS Therapeutics price target lowered to C$26.50 from C$33 at Clarus
03/18/22 Canaccord
HLS Therapeutics price target lowered to C$30.50 from C$30.75 at Canaccord
08/17/21 Raymond James
HLS Therapeutics upgraded to Outperform from Market Perform at Raymond James
IGXT IntelGenx
/

+

KDNY Chinook Therapeutics
$16.00 /

+0.865 (+5.72%)

02/01/22 H.C. Wainwright
H.C. Wainwright sees no negative read-through from Chinook CMO departure
MDNA Medicenna Therapeutics
$1.16 /

+0.06 (+5.45%)

03/15/22 H.C. Wainwright
Nektar failure has no read-through for Medicenna, says H.C. Wainwright
12/22/21 Oppenheimer
Medicenna preliminary MDNA11 data 'impressive,' says Oppenheimer
06/30/21 Maxim
Medicenna Therapeutics' MDNA11 could be 'best in class', says Maxim
06/01/21 H.C. Wainwright
Medicenna Therapeutics price target lowered to $7 from $8 at H.C. Wainwright
NVCN Neovasc
$6.15 /

-0.23 (-3.61%)

ONCY Oncolytics
$1.38 /

+0.06 (+4.55%)

01/27/22 Canaccord
Oncolytics price target lowered to $6 from $7 at Canaccord
PNT Point Biopharma
$8.88 /

+0.34 (+3.98%)

03/25/22 Piper Sandler
Point's path for PNT2002 de-risked by Novartis' approval, says Piper Sandler
12/01/21
Fly Intel: Top five analyst initiations
12/01/21 Brookline
Point Biopharma initiated with a Buy at Brookline
09/28/21 Piper Sandler
Point Biopharma exercises global license with Bach, says Piper Sandler
PROF Profound Medical
$7.62 /

+0.17 (+2.28%)

03/07/22 Cowen
Profound Medical price target lowered to $14 from $28 at Cowen
02/22/22 Raymond James
Profound Medical downgraded to Outperform from Strong Buy at Raymond James
05/13/21 Alliance Global Partners
Profound Medical price target lowered to $21 from $28.25 at Alliance Global
THER Theratechnologies
/

+

RPTX Repare Therapeutics
$11.52 /

+0.495 (+4.49%)

04/12/22 Stifel
Stifel downgrades Repare Therapeutics after 'blow to synthetic lethality thesis'
04/12/22 Stifel
Repare Therapeutics downgraded to Hold from Buy at Stifel
04/12/22 Piper Sandler
Repare Therapeutics price target lowered to $25 from $40 at Piper Sandler
03/17/22 Goldman Sachs
Repare Therapeutics assumed with a Buy at Goldman Sachs
XENE Xenon Pharmaceuticals
$29.08 /

+0.82 (+2.90%)

11/11/21 SVB Leerink
Xenon Pharmaceuticals price target raised to $40 from $34 at SVB Leerink
10/28/21 RBC Capital
Xenon Pharmaceuticals initiated with an Outperform at RBC Capital
10/06/21 Wedbush
Wedbush remains bullish on Xenon as financing gives firepower to advance XEN1101
10/04/21 Jefferies
Jefferies ups Xenon target to $50 after 'home run' epilepsy data
ZYME Zymeworks
$6.88 /

+0.76 (+12.42%)

03/15/22 Evercore ISI
Zymeworks initiated with an Outperform at Evercore ISI
02/28/22 Piper Sandler
Piper Sandler recommends ALX Oncology shares following 'quiet' Q4
02/28/22 Citi
Zymeworks price target lowered to $30 from $53 at Citi
02/09/22 Wells Fargo
Zymeworks price target lowered to $45 from $56 at Wells Fargo
ZYME Zymeworks
$6.88 /

+0.76 (+12.42%)

XENE Xenon Pharmaceuticals
$29.08 /

+0.82 (+2.90%)

RPTX Repare Therapeutics
$11.52 /

+0.495 (+4.49%)

PNT Point Biopharma
$8.88 /

+0.34 (+3.98%)

ONCY Oncolytics
$1.38 /

+0.06 (+4.55%)

MDNA Medicenna Therapeutics
$1.16 /

+0.06 (+5.45%)

KDNY Chinook Therapeutics
$16.00 /

+0.865 (+5.72%)

FUSN Fusion Pharmaceuticals
$5.17 /

+ (+0.00%)

FTRP Field Trip Health
$1.05 /

+ (+0.00%)

ESSA ESSA Bancorp
$17.25 /

-0.2 (-1.15%)

EPIX Essa Pharma
$5.80 /

+0.155 (+2.75%)

BLU Bellus Health
$8.97 /

+0.915 (+11.37%)

ABCL AbCellera
$8.08 /

+0.395 (+5.14%)

  • 27
    Jan
  • 15
    Dec
  • 10
    Nov
  • 28
    Oct
  • 06
    Oct
ZYME Zymeworks
$6.88 /

+0.76 (+12.42%)

RPTX Repare Therapeutics
$11.52 /

+0.495 (+4.49%)

PNT Point Biopharma
$8.88 /

+0.34 (+3.98%)

ESSA ESSA Bancorp
$17.25 /

-0.2 (-1.15%)

BLU Bellus Health
$8.97 /

+0.915 (+11.37%)

Conference/Events
Bloom Burton Securities to hold conference » 09:51
05/02/22
05/02
09:51
05/02/22
09:51
ABCL

AbCellera

$7.66 /

-0.025 (-0.33%)

, BLU

Bellus Health

$7.95 /

-0.1 (-1.24%)

, CHHHF

CareRx

$4.05 /

+ (+0.00%)

, EPIX

Essa Pharma

$5.54 /

-0.1 (-1.77%)

, ESSA

ESSA Bancorp

$17.45 /

+ (+0.00%)

, FTRP

Field Trip Health

$1.10 /

+0.05 (+4.76%)

, FUSN

Fusion Pharmaceuticals

$5.24 /

+0.07 (+1.35%)

, HLTRF

HLS Therapeutics

$10.96 /

+ (+0.00%)

, IGXT

IntelGenx

/

+

, KDNY

Chinook Therapeutics

$15.05 /

-0.08 (-0.53%)

, MDNA

Medicenna Therapeutics

$1.09 /

-0.01 (-0.91%)

, NVCN

Neovasc

$6.98 /

+0.6 (+9.40%)

, ONCY

Oncolytics

$1.32 /

+ (+0.00%)

, PNT

Point Biopharma

$8.49 /

-0.05 (-0.59%)

, PROF

Profound Medical

$7.28 /

-0.17 (-2.28%)

, THER

Theratechnologies

/

+

, RPTX

Repare Therapeutics

$10.84 /

-0.185 (-1.68%)

, XENE

Xenon Pharmaceuticals

$28.28 /

+0.02 (+0.07%)

, ZYME

Zymeworks

$5.93 /

-0.19 (-3.10%)

Healthcare Investor…

Healthcare Investor Conference to be held in Toronto, Canada on May 2-3.

ShowHide Related Items >><<
ZYME Zymeworks
$5.93 /

-0.19 (-3.10%)

XENE Xenon Pharmaceuticals
$28.28 /

+0.02 (+0.07%)

RPTX Repare Therapeutics
$10.84 /

-0.185 (-1.68%)

PROF Profound Medical
$7.28 /

-0.17 (-2.28%)

PNT Point Biopharma
$8.49 /

-0.05 (-0.59%)

ONCY Oncolytics
$1.32 /

+ (+0.00%)

NVCN Neovasc
$6.98 /

+0.6 (+9.40%)

MDNA Medicenna Therapeutics
$1.09 /

-0.01 (-0.91%)

KDNY Chinook Therapeutics
$15.05 /

-0.08 (-0.53%)

IGXT IntelGenx
/

+

HLTRF HLS Therapeutics
$10.96 /

+ (+0.00%)

FUSN Fusion Pharmaceuticals
$5.24 /

+0.07 (+1.35%)

FTRP Field Trip Health
$1.10 /

+0.05 (+4.76%)

EPIX Essa Pharma
$5.54 /

-0.1 (-1.77%)

BLU Bellus Health
$7.95 /

-0.1 (-1.24%)

ABCL AbCellera
$7.66 /

-0.025 (-0.33%)

ABCL AbCellera
$7.66 /

-0.025 (-0.33%)

04/28/22 Piper Sandler
AbCellera Q1 royalty estimate raised at Piper after Eli Lilly report
02/25/22 Piper Sandler
AbCellera price target lowered to $28 from $33 at Piper Sandler
02/11/22 Benchmark
AbCellera royalties could be 'substantial' from Lilly antibody, says Benchmark
12/21/21 Benchmark
AbCellera initiated with a Buy at Benchmark
BLU Bellus Health
$7.95 /

-0.1 (-1.24%)

02/24/22 H.C. Wainwright
Bellus Health price target raised to $16 from $14 at H.C. Wainwright
12/14/21 BTIG
Bellus Health price target raised to $18 from $13 at BTIG
12/13/21 BTIG
Bellus Health price target raised to $18 from $13 at BTIG
12/13/21 Evercore ISI
Bellus Health price target raised to $20 from $12 at Evercore ISI
CHHHF CareRx
$4.05 /

+ (+0.00%)

03/22/22 Desjardins
CareRx price target raised to C$10 from C$9.50 at Desjardins
11/10/21 Canaccord
CareRx price target raised to C$8.50 from C$8.25 at Canaccord
05/21/21 Desjardins
CareRx price target raised to C$10 from C$7.50 at Desjardins
05/20/21 Canaccord
CareRx price target raised to C$9 from C$7 at Canaccord
EPIX Essa Pharma
$5.54 /

-0.1 (-1.77%)

08/16/21 Oppenheimer
Essa Pharma price target lowered to $22 from $36 at Oppenheimer
08/16/21 Piper Sandler
Essa Pharma readout delay raises some concerns, says Pper Sandler
ESSA ESSA Bancorp
$17.45 /

+ (+0.00%)

FTRP Field Trip Health
$1.10 /

+0.05 (+4.76%)

02/17/22 Stifel
Field Trip Health price target lowered to C$10.50 from C$11.50 at Stifel
11/22/21 H.C. Wainwright
Field Trip Health price target raised to $25 from $20 at H.C. Wainwright
11/18/21 Stifel
Field Trip Health price target raised to C$11.50 from C$10 at Stifel
09/01/21 H.C. Wainwright
Field Trip Health initiated with a Buy at H.C. Wainwright
FUSN Fusion Pharmaceuticals
$5.24 /

+0.07 (+1.35%)

10/19/21 Morgan Stanley
Fusion Pharmaceuticals assumed with an Overweight at Morgan Stanley
08/26/21 B. Riley
B. Riley starts Fusion Pharmaceuticals with Buy, sees over 100% upside
08/26/21 B. Riley
Fusion Pharmaceuticals initiated with a Buy at B. Riley
HLTRF HLS Therapeutics
$10.96 /

+ (+0.00%)

04/27/22 Canaccord
HLS Therapeutics price target lowered to C$27 from C$30.50 at Canaccord
04/27/22 Clarus
HLS Therapeutics price target lowered to C$26.50 from C$33 at Clarus
03/18/22 Canaccord
HLS Therapeutics price target lowered to C$30.50 from C$30.75 at Canaccord
08/17/21 Raymond James
HLS Therapeutics upgraded to Outperform from Market Perform at Raymond James
IGXT IntelGenx
/

+

KDNY Chinook Therapeutics
$15.05 /

-0.08 (-0.53%)

02/01/22 H.C. Wainwright
H.C. Wainwright sees no negative read-through from Chinook CMO departure
MDNA Medicenna Therapeutics
$1.09 /

-0.01 (-0.91%)

03/15/22 H.C. Wainwright
Nektar failure has no read-through for Medicenna, says H.C. Wainwright
12/22/21 Oppenheimer
Medicenna preliminary MDNA11 data 'impressive,' says Oppenheimer
06/30/21 Maxim
Medicenna Therapeutics' MDNA11 could be 'best in class', says Maxim
06/01/21 H.C. Wainwright
Medicenna Therapeutics price target lowered to $7 from $8 at H.C. Wainwright
NVCN Neovasc
$6.98 /

+0.6 (+9.40%)

ONCY Oncolytics
$1.32 /

+ (+0.00%)

01/27/22 Canaccord
Oncolytics price target lowered to $6 from $7 at Canaccord
PNT Point Biopharma
$8.49 /

-0.05 (-0.59%)

03/25/22 Piper Sandler
Point's path for PNT2002 de-risked by Novartis' approval, says Piper Sandler
12/01/21
Fly Intel: Top five analyst initiations
12/01/21 Brookline
Point Biopharma initiated with a Buy at Brookline
09/28/21 Piper Sandler
Point Biopharma exercises global license with Bach, says Piper Sandler
PROF Profound Medical
$7.28 /

-0.17 (-2.28%)

03/07/22 Cowen
Profound Medical price target lowered to $14 from $28 at Cowen
02/22/22 Raymond James
Profound Medical downgraded to Outperform from Strong Buy at Raymond James
05/13/21 Alliance Global Partners
Profound Medical price target lowered to $21 from $28.25 at Alliance Global
THER Theratechnologies
/

+

RPTX Repare Therapeutics
$10.84 /

-0.185 (-1.68%)

04/12/22 Stifel
Stifel downgrades Repare Therapeutics after 'blow to synthetic lethality thesis'
04/12/22 Stifel
Repare Therapeutics downgraded to Hold from Buy at Stifel
04/12/22 Piper Sandler
Repare Therapeutics price target lowered to $25 from $40 at Piper Sandler
03/17/22 Goldman Sachs
Repare Therapeutics assumed with a Buy at Goldman Sachs
XENE Xenon Pharmaceuticals
$28.28 /

+0.02 (+0.07%)

11/11/21 SVB Leerink
Xenon Pharmaceuticals price target raised to $40 from $34 at SVB Leerink
10/28/21 RBC Capital
Xenon Pharmaceuticals initiated with an Outperform at RBC Capital
10/06/21 Wedbush
Wedbush remains bullish on Xenon as financing gives firepower to advance XEN1101
10/04/21 Jefferies
Jefferies ups Xenon target to $50 after 'home run' epilepsy data
ZYME Zymeworks
$5.93 /

-0.19 (-3.10%)

03/15/22 Evercore ISI
Zymeworks initiated with an Outperform at Evercore ISI
02/28/22 Piper Sandler
Piper Sandler recommends ALX Oncology shares following 'quiet' Q4
02/28/22 Citi
Zymeworks price target lowered to $30 from $53 at Citi
02/09/22 Wells Fargo
Zymeworks price target lowered to $45 from $56 at Wells Fargo
ZYME Zymeworks
$5.93 /

-0.19 (-3.10%)

XENE Xenon Pharmaceuticals
$28.28 /

+0.02 (+0.07%)

RPTX Repare Therapeutics
$10.84 /

-0.185 (-1.68%)

PNT Point Biopharma
$8.49 /

-0.05 (-0.59%)

ONCY Oncolytics
$1.32 /

+ (+0.00%)

MDNA Medicenna Therapeutics
$1.09 /

-0.01 (-0.91%)

KDNY Chinook Therapeutics
$15.05 /

-0.08 (-0.53%)

FUSN Fusion Pharmaceuticals
$5.24 /

+0.07 (+1.35%)

FTRP Field Trip Health
$1.10 /

+0.05 (+4.76%)

ESSA ESSA Bancorp
$17.45 /

+ (+0.00%)

EPIX Essa Pharma
$5.54 /

-0.1 (-1.77%)

BLU Bellus Health
$7.95 /

-0.1 (-1.24%)

ABCL AbCellera
$7.66 /

-0.025 (-0.33%)

  • 27
    Jan
  • 15
    Dec
  • 10
    Nov
  • 28
    Oct
  • 06
    Oct
ZYME Zymeworks
$5.93 /

-0.19 (-3.10%)

RPTX Repare Therapeutics
$10.84 /

-0.185 (-1.68%)

PNT Point Biopharma
$8.49 /

-0.05 (-0.59%)

ESSA ESSA Bancorp
$17.45 /

+ (+0.00%)

BLU Bellus Health
$7.95 /

-0.1 (-1.24%)

Over a month ago
Recommendations
CareRx price target raised to C$10 from C$9.50 at Desjardins » 11:22
03/22/22
03/22
11:22
03/22/22
11:22
CHHHF

CareRx

$4.16 /

+0.26 (+6.67%)

Desjardins analyst David…

Desjardins analyst David Newman raised the firm's price target on CareRx to C$10 from C$9.50 and keeps a Buy rating on the shares.

ShowHide Related Items >><<
CHHHF CareRx
$4.16 /

+0.26 (+6.67%)

11/10/21 Canaccord
CareRx price target raised to C$8.50 from C$8.25 at Canaccord
05/21/21 Desjardins
CareRx price target raised to C$10 from C$7.50 at Desjardins
05/20/21 Canaccord
CareRx price target raised to C$9 from C$7 at Canaccord
Over a quarter ago
Recommendations
CareRx price target raised to C$8.50 from C$8.25 at Canaccord » 12:39
11/10/21
11/10
12:39
11/10/21
12:39
CHHHF

CareRx

$3.86 /

+ (+0.00%)

Canaccord analyst Tania…

Canaccord analyst Tania Gonsalves raised the firm's price target on CareRx to C$8.50 from C$8.25 and keeps a Buy rating on the shares.

ShowHide Related Items >><<
CHHHF CareRx
$3.86 /

+ (+0.00%)

05/21/21 Desjardins
CareRx price target raised to C$10 from C$7.50 at Desjardins
05/20/21 Canaccord
CareRx price target raised to C$9 from C$7 at Canaccord
03/11/21 Canaccord
CareRx price target raised to C$7 from C$6.50 at Canaccord
02/04/21 Desjardins
CareRx initiated with a Buy at Desjardins
Recommendations
CareRx price target raised to C$10 from C$7.50 at Desjardins » 12:00
05/21/21
05/21
12:00
05/21/21
12:00
CHHHF

CareRx

$5.41 /

+0.4417 (+8.89%)

Desjardins analyst David…

Desjardins analyst David Newman raised the firm's price target on CareRx to C$10 from C$7.50 and keeps a Buy rating on the shares.

ShowHide Related Items >><<
CHHHF CareRx
$5.41 /

+0.4417 (+8.89%)

05/20/21 Canaccord
CareRx price target raised to C$9 from C$7 at Canaccord
03/11/21 Canaccord
CareRx price target raised to C$7 from C$6.50 at Canaccord
02/04/21 Desjardins
CareRx initiated with a Buy at Desjardins
12/15/20 Industrial Alliance
CareRx initiated with a Buy at Industrial Alliance

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.